新辅助化疗在局部晚期食管癌中的应用进展(4)
[15]Ando N，Kato H，Igaki H，et al.A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus(JCOG9907)[J].Ann Surg Oncol，2012，19(1)：68-74.
[16]Haisley KR，Hart KD，Nabavizadeh N，et al.Neoadjuvant chemoradiotherapy with concurrent cisplatin 5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin paclitaxel in patients with locally advanced esophageal cancer[J].Dis Esophagus，2017，30(7)：1-7.
[17]Polee MB，Tilanus HW，Eskens FA，et al.Phase Ⅱ study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus[J].Ann Oncol，2003，14(8)：1253-1257.
[18]Bushan K，Sharma S.Neoadjuvant chemotherapy and surgery versus surgery alone in resectable esophageal cancer[J].Indian J Cancer，2015，52(3)：413-416.
[19]Mehta SP，Jose P，Mirza A，et al.Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery[J].Dis Esophagus，2013，26(2)：182-188.
[20]Watanabe M，Nagai Y，Kinoshita K，et al.Induction chemotherapy with docetaxelcisplatin5-fluorouracil for patients with node-positive esophageal cancer[J].Digestion，2011，83(3)：146-152.
編辑/成森, http://www.100md.com(胡国梁 杜铭)
[16]Haisley KR，Hart KD，Nabavizadeh N，et al.Neoadjuvant chemoradiotherapy with concurrent cisplatin 5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin paclitaxel in patients with locally advanced esophageal cancer[J].Dis Esophagus，2017，30(7)：1-7.
[17]Polee MB，Tilanus HW，Eskens FA，et al.Phase Ⅱ study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus[J].Ann Oncol，2003，14(8)：1253-1257.
[18]Bushan K，Sharma S.Neoadjuvant chemotherapy and surgery versus surgery alone in resectable esophageal cancer[J].Indian J Cancer，2015，52(3)：413-416.
[19]Mehta SP，Jose P，Mirza A，et al.Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery[J].Dis Esophagus，2013，26(2)：182-188.
[20]Watanabe M，Nagai Y，Kinoshita K，et al.Induction chemotherapy with docetaxelcisplatin5-fluorouracil for patients with node-positive esophageal cancer[J].Digestion，2011，83(3)：146-152.
編辑/成森, http://www.100md.com(胡国梁 杜铭)
参见：首页 > 医疗版 > 疾病专题 > 消化内科 > 食管疾病 > 食管癌